Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05793957 | COMPLETED | Hematopoietic and Lymphoid System Neoplasm

Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms
Sponsor:

OHSU Knight Cancer Institute

Information provided by (Responsible Party):

Ryan Li, MD

Brief Summary:

This clinical trial evaluates the use of virtual reality (VR) goggles during chemotherapy infusion to reduce anxiety-related symptoms in patients with head and neck, thoracic, hematologic, and breast cancers. Virtual reality headsets provide the ability for users to explore a simulated, three-dimensional environment with which users can interact. In virtual reality users can play interactive games, enjoy relaxing experiences, and watch immersive videos. The use of VR goggles may help with anxiety management during chemotherapy infusion.

Condition or disease

Hematopoietic and Lymphoid System Neoplasm

Malignant Breast Neoplasm

Malignant Head and Neck Neoplasm

Malignant Solid Neoplasm

Malignant Thoracic Neoplasm

Intervention/treatment

Questionnaire Administration

Telephone-Based Intervention

Virtual Technology Intervention

Phase

NA

Detailed Description:

PRIMARY OBJECTIVE: I. To evaluate the effectiveness of VR therapy in reducing severity of anxiety symptoms during chemotherapy infusion, compared to participants utilizing a smartphone as a control. SECONDARY OBJECTIVES: I. To evaluate whether there is a short-term effect of VR use in anxiety levels. II. To assess participant satisfaction with their chemotherapy infusion experience in the control and treatment groups. EXPLORATORY OBJECTIVE: I. To assess participants' reported adverse effects associated with VR headset use. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP 1: Patients use VR during chemotherapy infusion on study. GROUP 2: Patients use smartphone during chemotherapy infusion on study.

Study Type : INTERVENTIONAL
Estimated Enrollment : 50 participants
Masking : NONE
Primary Purpose : SUPPORTIVE_CARE
Official Title : Anxiety in the Context of Chemotherapy Infusion: Is There an Association Between the Use of Virtual Reality Goggles and Changes in Anxiety-Related Symptoms?
Actual Study Start Date : 2023-04-20
Estimated Primary Completion Date : 2023-09-28
Estimated Study Completion Date : 2023-09-28

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 89 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * English speaking: Ability to interact with virtual reality content may be impacted by inability to understand English; moreover, paper questionnaires will only be provided in English.
  • * Older than 18 years of age, and younger than 89 years of age. All sexes/gender identities and members of all races and ethnic groups will be included.
  • * Planned to receive chemotherapy infusion for head and neck, breast, thoracic, and hematologic cancers at the Oregon Health \& Science University (OHSU) South Waterfront Center for Health \& Healing building 2 (there are no restrictions related to prior chemotherapy infusions or other cancer treatments).
  • * Chemotherapy treatment lasting at least 10 minutes.
  • * Ability to understand and willingness to sign a written informed consent document.
Exclusion Criteria
  • * Social or psychiatric conditions that may interfere with compliance.
  • * Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset. This would limit the ability to utilize the VR headset.
  • * History of seizure or epilepsy.
  • * History of vertigo or persistent dizziness.
  • * Use of cardiac pacemaker, requirement for hearing aid on at all times, or have defibrillators.
  • * Children.
  • * Pregnant women.
  • * Decisionally impaired adults.
  • * Prisoners.
Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms

Location Details

NCT05793957

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, Oregon

OHSU Knight Cancer Institute

Portland, Oregon, United States, 97239